General And Administrative Expense in USD of Quantum Biopharma Ltd. from 2019 to 2024

Taxonomy & unit
ifrs-full: USD and CAD
Summary
Quantum Biopharma Ltd. quarterly and annual General And Administrative Expense history and change rate from 2019 to 2024.
  • Quantum Biopharma Ltd. General And Administrative Expense for the quarter ending 30 Sep 2024 was $3,250,030, a 5.8% increase year-over-year.
  • Quantum Biopharma Ltd. annual General And Administrative Expense for 2024 was $9,410,097, a 4.2% increase from 2023.
  • Quantum Biopharma Ltd. annual General And Administrative Expense for 2023 was $9,032,724, a 37% decline from 2022.
  • Quantum Biopharma Ltd. annual General And Administrative Expense for 2022 was $14,450,094, a 9.3% decline from 2021.
Source SEC data
View on sec.gov
General And Administrative Expense, Quarterly (USD)
General And Administrative Expense, YoY Quarterly Change (%)
General And Administrative Expense, Annual (USD)
General And Administrative Expense, YoY Annual Change (%)

Quantum Biopharma Ltd. Quarterly General And Administrative Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $3,250,030 +$178,141 +5.8% 01 Jul 2024 30 Sep 2024 6-K 12 Nov 2024 2024 Q3
Q2 2024 $2,310,283 +$439,525 +23% 01 Apr 2024 30 Jun 2024 6-K/A 19 Aug 2024 2024 Q2
Q3 2023 $3,071,889 01 Jul 2023 30 Sep 2023 6-K 12 Nov 2024 2024 Q3
Q2 2023 $1,870,758 01 Apr 2023 30 Jun 2023 6-K/A 19 Aug 2024 2024 Q2

Quantum Biopharma Ltd. Annual General And Administrative Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $9,410,097 +$377,373 +4.2% 01 Jan 2024 31 Dec 2024 20-F 28 Mar 2025 2024 FY
2023 $9,032,724 -$5,417,370 -37% 01 Jan 2023 31 Dec 2023 20-F 28 Mar 2025 2024 FY
2022 $14,450,094 -$1,476,009 -9.3% 01 Jan 2022 31 Dec 2022 20-F 28 Mar 2025 2024 FY
2021 $15,926,103 +$5,868,020 +58% 01 Jan 2021 31 Dec 2021 20-F 02 Apr 2024 2023 FY
2020 $10,058,083 +$1,650,656 +20% 01 Jan 2020 31 Dec 2020 20-F 31 Mar 2023 2022 FY
2019 $8,407,427 01 Jan 2019 31 Dec 2019 20-F 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.